Miura, Takaaki
Chugai Pharmaceutical Co., Ltd. (Japan)
2 papers on CoChatORCID 0009-0009-0834-7328
Most cited papers
- Verified
Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors
Lito, P., Saborowski, A., Yue, J., Solomon, M., Joseph, E., Gadal, S., Saborowski, M., Kastenhuber, E., Fellmann, C., Ohara, K., et al. (2014) · Cancer Cell
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 324
- Verified
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity
Ishii, N., Harada, N., Joseph, E. W., Ohara, K., Miura, T., Sakamoto, H., Matsuda, Y., Tomii, Y., Tachibana-Kondo, Y., Iikura, H., et al. (2013) · Cancer Research
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 179
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free